This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nec Corporation, Tokyo Medical University. Active years: 2014-2015.
Location History:
- Suginami-ku, JP (2014)
- Tokyo, JP (2015)
Company Filing History:
2 out of 36,676 
2 out of 11 Years Active: 2014-2015
Title: Seiko Iizuka: Innovator in Cancer Marker Research
Introduction
Seiko Iizuka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of cancer research, particularly in the development of novel cancer markers. With a total of 2 patents, her work focuses on improving cancer evaluation methods.
Latest Patents
Iizuka's latest patents include a cancer marker and a method for evaluating cancer using this marker. The invention provides a novel cancer marker for assessing the onset, preclinical stage, clinical stage, or prognosis of cancer in a subject. The cancer marker comprises at least one miRNA selected from hsa-miR-92 and hsa-miR-494, specifically for cancers excluding breast cancer. The evaluation method involves detecting the expression level of the cancer marker in a biological sample collected from a subject.
Career Highlights
Throughout her career, Seiko Iizuka has worked with notable organizations such as NEC Corporation and Tokyo Medical University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Iizuka has collaborated with esteemed colleagues, including Kosuke Oikawa and Takayuki Mizutani. These partnerships have further enriched her research endeavors and fostered innovation in cancer diagnostics.
Conclusion
Seiko Iizuka's work in cancer marker research exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her significant impact in the field of cancer evaluation.